2021
Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation
Saeed O, Zhang S, Patel S, Jorde U, Garcia M, Bulcha N, Gupta T, Xian Y, Matsouaka R, Shah S, Smith E, Schwamm L, Fonarow G. Oral Anticoagulation and Adverse Outcomes after Ischemic Stroke in Heart Failure Patients without Atrial Fibrillation. Journal Of Cardiac Failure 2021, 27: 857-864. PMID: 33975786, PMCID: PMC8355019, DOI: 10.1016/j.cardfail.2021.02.017.Peer-Reviewed Original ResearchConceptsOral anticoagulationRecurrent ischemic strokeAcute ischemic strokeIschemic strokeHeart failureAtrial fibrillationOlder patientsHistory of HFInitiation of OACCox proportional hazard ratiosProportional hazard ratiosHeart failure patientsKaplan-Meier curvesClinical registry dataCause bleedingEligible patientsAdverse eventsCumulative incidenceFailure patientsHazard ratioSuch patientsYear mortalityAdverse outcomesClinical covariatesRegistry data
2011
Predictors of Hospital Length of Stay in Heart Failure: Findings from Get With the Guidelines
Whellan D, Zhao X, Hernandez A, Liang L, Peterson E, Bhatt D, Heidenreich P, Schwamm L, Fonarow G. Predictors of Hospital Length of Stay in Heart Failure: Findings from Get With the Guidelines. Journal Of Cardiac Failure 2011, 17: 649-656. PMID: 21807326, DOI: 10.1016/j.cardfail.2011.04.005.Peer-Reviewed Original ResearchConceptsStandard laboratory evaluationBrain natriuretic peptideHospital characteristicsPatient characteristicsMore comorbiditiesHospital lengthLonger LOSGuidelines-Heart FailureAdmission vital signsHeart failure patientsTime of admissionBNP levelsHF patientsFailure patientsHeart failureNatriuretic peptideClinical variablesPatient admissionsPatientsDisease severityVital signsHigher disease severityAdmissionLOS variationAdmission predictors